Nordictest

Hometests

Hometests.online sells direct-to-consumer rapid self-test kits covering fertility (ovulation, pregnancy), men’s health, UTI, cholesterol, vitamin deficiencies, allergies, diabetes and infectious diseases. Most single-use tests sit in the budget-to-mid price band (US $10–35), while multi-pack fertility or health-monitoring bundles reach ≈ US $70. The entire catalogue is sold only through the brand’s own website, with free U.S. shipping on orders over $25 and bulk discounts for clinics. The company positions itself on FDA-cleared/CE-marked accuracy, 5-minute read times and discreet doorstep delivery; every kit ships with printed step-by-step instructions and a QR code that opens a live chat with a licensed nurse. Its best-known SKUs are the “Early-10” hCG pregnancy strip (detects 10 mIU/ml) and the “Ovuline 50-pack” that tracks a full 5-cycle window. All tests are manufactured in an ISO 13485 facility and individually foil-sealed for 24-month shelf life. Core buyers are 20-40-year-old women managing fertility, budget-conscious households who want to avoid clinic co-pays, and privacy-minded consumers testing for UTIs or STIs. The brand speaks to values of autonomy, speed and confidentiality—appealing to people who track health metrics at home and share results only when they choose. Hometests competes with pharmacy-shelf diagnostic brands and telehealth labs that add subscription or consultation fees. It differentiates through lower unit cost, no-app operation, nurse chat included in the purchase price, and flat-rate bulk pricing that undercuts both retail mark-ups and subscription models.

Know your body first, tell the world later

Bluecrest Wellness

Bluecrest Wellness sells at-home blood-testing packages that screen for heart, diabetes, kidney, liver, thyroid, hormone, vitamin and cancer-risk biomarkers. Kits are priced £39–£249, siting the brand in the mid-range between NHS surcharge tests and high-end concierge diagnostics. Customers order online, collect finger-prick samples at home or in 200+ partner pharmacies, then receive a GP-reviewed PDF report within 3–5 days. The company’s core promise is “hospital-grade results without hospital waiting lists,” achieved through UKAS-accredited labs and NHS-qualified GPs who flag out-of-range values within 24 hours. All results are explained in plain-English dashboards and backed by free nurse follow-up calls, a service layer rarely bundled at this price. Their flagship “Complete Health” panel—over 50 biomarkers for £149—is the best-selling test and frequently corporate-funded as an employee benefit. Typical buyers are 30-55-year-old professionals who want preventive insight but lack time for GP referrals; 40 % of orders come from corporate HR schemes. The brand appeals to data-driven, health-curious consumers who track fitness metrics and value speed, confidentiality and clinical credibility over pure bargain pricing. Bluecrest competes with direct-to-consumer kit brands, pharmacy-led testing services and private hospital walk-in clinics. It differentiates by combining nationwide pharmacy sample-drop sites, UKAS lab accuracy and human clinician after-care at a mid-tier price, positioning itself as a faster, more supportive bridge between public healthcare and premium private medicine.

Know your health before your doctor does

Biosuretest

Biosuretest sells at-home diagnostic test kits for HIV, syphilis, hepatitis C and COVID-19; accessories such as lancets, buffer solution and single-use gloves are bundled or sold separately. Kits are priced mid-range: £25–£40 for a single HIV self-test, £50–£90 for multi-infection packs. Sales are online-only through the brand’s UK and EU webstores and selected pharmacy marketplaces; no high-street retail presence is listed. The brand positions itself on CE-certified, 99.7 % accurate finger-prick tests that give a visual result in 15 minutes without sending samples to a lab. Biosuretest’s flagship product is the BioSURE HIV Self Test, the first legally approved HIV self-test manufactured in the UK. All tests are supplied with encrypted online instructions, video support and optional next-day discreet delivery. Primary buyers are sexually-active adults 18-45 who want routine or post-exposure screening without clinic visits; the brand also serves NGOs and university outreach programmes. Messaging stresses privacy, autonomy and normalising regular STI testing; packaging is plain, gender-neutral and recyclable to align with values of discretion and sustainability. Biosuretest competes with other direct-to-consumer diagnostic brands that rely on laboratory return samples or subscription models. It differentiates by offering true self-tests that require no lab processing, a one-off purchase option, UK-based manufacturing for faster domestic shipping, and dedicated sexual-health customer support seven days a week.

Know your status in 15 minutes, from home, with real privacy

• Sustainable
• Recycled

Defyithealth

Defyithealth sells a tightly edited line of science-backed supplements and at-home health test kits priced in the mid-range tier—most SKUs fall between $29 and $79. All commerce is handled through its own Shopify-powered site; no third-party marketplaces or brick-and-mortar presence are used. The brand positions itself on “data-first wellness,” pairing each supplement with an optional finger-prick or saliva test so customers can measure biomarkers before and after use. Flagship SKUs include a vitamin D + K2 combo sold alongside a 25-OH-D blood spot test and a “Metabolic Reset” bundle that bundles berberine, chromium and a two-pack HbA1c test. Core buyers are 25-45-year-old professionals who already track sleep, steps or macros and want quantifiable proof that a pill works. They value transparency, open-source ingredient sheets and the ability to retest without a doctor’s visit. Defyithealth competes with both direct-to-consumer vitamin brands and emerging tele-health labs; it differentiates by integrating the two experiences under one vertically controlled system, cutting third-party lab mark-ups and publishing anonymized aggregate results on its site for peer comparison.

Prove your supplements work with your own biomarker data

MyStartHealth

MyStartHealth sells at-home lab test kits that screen fertility, thyroid, cardiovascular, and metabolic health; single tests run $59-$99, while multi-panel “Baseline” bundles reach $199. All products are positioned in the mid-range tier and are sold exclusively through the brand’s own e-commerce site, with free first-class shipping to the lower 48 states. The company differentiates itself by pairing every kit with a telehealth consult and a personalized physician-reviewed action plan included in the price; results are delivered through a HIPAA-compliant dashboard within 5 days of sample receipt. Its best-known SKU is the “Couples Fertility Starter,” which tests 11 biomarkers for both partners in one combined package. Primary buyers are 25-40-year-old professionals and engaged couples who want baseline health data before trying to conceive or making lifestyle changes; they value speed, privacy, and medical guidance without visiting a clinic. The brand speaks to proactive, tech-savvy consumers who track sleep, nutrition, and fitness metrics and prefer subscription-free, pay-as-you-go testing. MyStartHealth competes with direct-to-consumer lab platforms and big-box retail mini-lab kiosks; it separates itself by bundling physician oversight and a tailored next-step plan at no extra cost, whereas rivals often upsell consultations or leave users to interpret raw data alone.

Know your body before life's biggest decisions

Questhealth

Questhealth sells direct-to-consumer lab testing packages that measure everything from routine cholesterol to hormone, vitamin, allergy and genomics panels. Kits are priced $49-$399 (mid-range), with most falling between $99-$199; customers can add physician oversight and subscription re-testing for extra fees. All orders are placed through questhealth.com; digital results post to a secure portal within days and can be shared with any provider. The brand leverages Quest Diagnostics’ CLIA-certified national lab network, so tests are processed in the same facilities used by doctors and hospitals, giving consumer-initiated tests medical-grade accuracy. Notable products include the “Baseline” wellness panel, “Thyroid Insight,” “Food Allergy Panel,” and a COVID-19 antibody test launched during the pandemic that became a top-seller. Every result includes plain-language explanations and optional telehealth consults, positioning Questhealth as a bridge between at-home convenience and clinical credibility. Target customers are health-conscious adults aged 25-55 who want data to optimize fitness, nutrition, or chronic-condition management without waiting for a doctor’s order. They value transparency, preventive care, and the ability to track biomarkers over time; many are subscribers who retest quarterly to measure lifestyle changes. Questhealth competes with other online lab marketplaces and at-home sample-collection startups, differentiating through its own brick-and-mortar lab infrastructure that eliminates third-party outsourcing and keeps turnaround times under 48 hours for most tests. By combining physician network integration, insurance-compatible pricing, and the trust of a 50-year-old diagnostic leader, it offers medical-lab rigor that purely e-commerce competitors cannot match.

Know your body before your doctor needs to

Verolabs

Verolabs sells at-home diagnostic and wellness products that pair with a smartphone app: rapid STI tests, fertility hormone kits, vitamin-D strips, UTI screens, and a COVID/flu combo test. All items are sold direct-to-consumer through verolabs.com and ship in discreet packaging; prices sit in the mid-range bracket, with most single-use kits between $35-$79 and multi-test bundles up to $149. The brand operates online only and offers subscription re-ordering for repeat tests. The company’s core edge is CLIA-waived, FDA-cleared lateral-flow chemistry that returns clinically valid results in 15 minutes and syncs automatically to the free Vero app for encrypted sharing with physicians or partners. Each kit contains a mini-spectrometer dongle that calibrates the assay against a printed QR card, removing visual guesswork and allowing quantitative readouts from a single drop of blood, saliva, or urine. This hardware-plus-software platform has made their STI trio (HIV, syphilis, chlamydia) one of the best-selling DTC sexual-health tests in the U.S. since its 2022 launch. Customers are 20-40-year-old urban professionals who want lab-grade data without clinic wait times, co-pays, or insurance paperwork; 60 % identify as female and cite “privacy first” as the primary purchase driver. The brand speaks to sex-positive, preventative lifestyles and markets heavily on TikTok and Instagram with the tagline “Know today, live tomorrow,” aligning with values of bodily autonomy, transparency, and tech-enabled convenience. Verolabs competes in the crowded at-home diagnostics space against strip-only kits that rely on color matching and against mail-in lab services with 2-5 day turnaround. It differentiates by delivering instrument-read, physician-verified results in minutes while still undercutting traditional lab fees, and by bundling encrypted result sharing and longitudinal tracking inside one ecosystem.

Lab results in your pocket, privacy in your control

UCARI

UCARI sells at-home intolerance, allergy and sensitivity test kits that screen hair or saliva samples against 1,000+ food, environmental and pet triggers. Kits are priced $79-$149, situating the brand in the mid-range tier between $30 drug-store strip tests and $300+ clinical lab panels. Sales are online-direct only; customers collect the sample at home, mail it to UCARI’s Florida lab and receive a digital report within 2-5 days. The company’s USP is a bioresonance scanning method that claims to detect IgE, IgG4 and energetic stress responses without blood draws, plus a free nutritionist consult with every kit. A “Pet Test” for dogs and cats and a “Couples Test” bundle are best-sellers that distinguish UCARI from single-human-focused rivals. Results are color-coded in an app that links to substitute-product shopping lists, reinforcing the brand’s wellness-ecosystem positioning. Core buyers are 25-45-year-old health-conscious women, often moms or pet owners, who suspect undiagnosed bloating, skin flare-ups or behavioral issues and want actionable data before committing to elimination diets or veterinary drugs. The brand appeals to value-driven shoppers who prefer non-invasive science, digital convenience and control over in-clinic appointments. UCARI competes with direct-to-consumer blood-spot labs, hair-analysis startups and retail antigen kits. It differentiates through lower sample friction (no needles or stool), faster turnaround, bundled human-and-pet testing and post-result guidance, positioning itself as an affordable wellness screening tool rather than a medical diagnostic.

Know what's really bugging you, your pet and your skin